34.84 -0.45 (-1.28%)
ACOR
Stock Details
Last Trade:34.84 Change:-0.45 (-1.28%) Prev Close:35.29 Open: 35.25 Days Range:34.84 – 36.00 52 Week Range: 15.52 - 36.49 Volume:1011241 P/E: N/AEPS:-2.22
View AllRecent Alerts 03/20/10
Recent Alert on 03/10/10 at 8:53am
'Takeover Fever' Continues In Biotech After Facet (FACT) Deal, Who's Next?
'Takeover Fever' Continues In Biotech After Facet (FACT) Deal, Who's Next?
'Takeover Fever' in biotech land is sure to continue today after Facet Biotech Corporation (Nasdaq: FACT) agreed to be acquired by Abbott (NYSE: ABT) for $27 per share, which is a 67% premium to yesterday's close and a 54% premium to a rejected... Read More
Recent Alert on 03/10/10 at 8:53am
'Takeover Fever' Continues In Biotech After Facet (FACT) Deal, Who's Next?
'Takeover Fever' Continues In Biotech After Facet (FACT) Deal, Who's Next?
Recent Alert on 03/01/10 at 8:13am
Acorda Therapeutics (ACOR) MS Treatment AMPYRA Available in U.S. and Puerto Rico
Acorda Therapeutics (ACOR) MS Treatment AMPYRA Available in U.S. and Puerto Rico
Recent Alert on 03/01/10 at 8:13am
Acorda Therapeutics (ACOR) MS Treatment AMPYRA Available in U.S. and Puerto Rico
Acorda Therapeutics (ACOR) MS Treatment AMPYRA Available in U.S. and Puerto Rico
Recent Alert on 02/23/10 at 7:36am
Acorda Therapeutics (ACOR) Posts Q4 Loss of $0.59, In-Line with Views
Acorda Therapeutics (ACOR) Posts Q4 Loss of $0.59, In-Line with Views
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 02/18/10 at 11:40am
Analyst Upgrades, Downgrades and Initiations: CTXS, DE, GPI, NTAP, VMI, XNPT ...
Analyst Upgrades, Downgrades and Initiations: CTXS, DE, GPI, NTAP, VMI, XNPT ...